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Here we show that Rab25 permits the sorting of
ligand-occupied, active-conformation a5b1 integrin
to late endosomes/lysosomes. Photoactivation and
biochemical approaches show that lysosomally tar-
geted integrins are not degraded but are retrogradely
transported and recycled to the plasmamembrane at
the back of invading cells. This requires CLIC3,
a protein upregulated in Rab25-expressing cells
and tumors, which colocalizes with active a5b1 in
late endosomes/lysosomes. CLIC3 is necessary for
release of the cell rear during migration on 3D
matrices and is required for invasion and mainte-
nance of active Src signaling in organotypicmicroen-
vironments. CLIC3 expression predicts lymph node
metastasis and poor prognosis in operable cases of
pancreatic ductal adenocarcinoma (PDAC). The
identification of CLIC3 as a regulator of a recycling
pathway and as an independent prognostic indicator
in PDAC highlights the importance of active integrin
trafficking as a potential drive to cancer progression
in vivo.
INTRODUCTION
Metastasizing cells need to invade the extracellular matrix (ECM)
that surrounds tissues and tumors, and must survive and grow
within these microenvironments (Sahai, 2005). As they invade,
tumor cells form dynamic interactions with the ECM that not
only provide traction force for forward motion and ECM remod-
eling but also promote cell growth and survival (Kumar and
Weaver, 2009). Both the motility and the growth and survival of
tumor cells are controlled by integrins: transmembrane proteins
that interact extracellularly with ECM proteins, such as fibro-
nectin and collagen, and intracellularly with the cytoskeletonDevelopmand the cell’s signaling and vesicular transport machinery
(Caswell et al., 2009; Hynes, 2002). Although the ECM protein,
fibronectin, is not normally found in adult tissue, it is a very
abundant component of the tumor-associated ECM (Zetter,
1993), and the cell’s major fibronectin-binding integrin (a5b1) is
key to the survival (Lee and Juliano, 2000; O’Brien et al., 1996;
Zhang et al., 1995) and migration (Caswell et al., 2007, 2008;
Muller et al., 2009) of tumor cells.
a5b1 is continuously endocytosed and then returned, or
recycled, to the plasma membrane via Rab11- and Arf6- depen-
dent pathways (Powelka et al., 2004; Roberts et al., 2001; Tayeb
et al., 2005). Membrane trafficking pathways mediating a5b1
recycling influence its capacity to promote cancer invasion.
Expression of p53mutants or inhibition of avb3 integrin can drive
recruitment of the Rab11 effector, Rab-coupling protein (RCP),
to the cytotail of b1 integrin, which then enables RCP to asso-
ciate with the EGF receptor 1 (EGFR1). a5b1 and EGFR1 are
then coordinately recycled to the plasma membrane in a way
that potentiates EGFR1 signaling to Akt, a kinase that promotes
invasion (Caswell et al., 2008; Muller et al., 2009), cell growth,
and survival.
Another Rab11 family member, Rab25, is associated with
aggressive cancers (Caswell et al., 2007; Cheng et al., 2004),
and drives invasion by binding to a5b1 to control its recruitment
to the tips of invasive projections (Caswell et al., 2007). There is
also evidence that Rab25 can suppress tumor progression. Nam
et al. (2010) have shown that loss of Rab25 promotes intestinal
neoplasia, and low levels of Rab25 are associated with human
colorectal cancer. Rao and coworkers (Cheng et al., 2006,
2010) have found that Rab25 expression is reduced in many
breast tumors, and its loss in estrogen-receptor-negative breast
cancer cell lines promotes aggression. These discrepancies
led us to further investigate the mechanisms by which Rab25
influences invasive behavior in vitro and the progression of
cancer in vivo. We show that Rab25 directs conformationally
active a5b1 integrin to the lysosome. Lysosomally routed a5b1
is not degraded but is rapidly recycled to the plasma mem-
brane via a pathway requiring the Chloride Intracellular Channel
Protein 3 (CLIC3). CLIC3 is required for cell migration and isental Cell 22, 131–145, January 17, 2012 ª2012 Elsevier Inc. 131
Figure 1. CLIC3 Is Upregulated in Rab25-Expressing A2780 Cells
(A) A2780 cells expressing Rab25 or a control vector (DNA3) were seeded onto plastic or CDM, and genes differentially expressed in Rab25 cells were ordered by
decreasing p value. Data are mean from three independent experiments. See also Table S1.
(B and C) CLIC3 mRNA levels (normalized to b-actin or GAPDH) of cells plated onto plastic or CDM were assessed by qPCR, with Rab11 and Rab25
being suppressed using shRNAi as indicated. Data in (B) are mean ± SEM of three independent experiments. Suppression of Rabs was verified by western
blotting.
(D) Western blots indicating antibody specificity for CLIC3 (but not GST-tagged CLICs 1 and 4). Protein loading was confirmed by probing with anti-GST.
(E) A2780-DNA3 and A2780-Rab25 lysates were immunoblotted for CLIC3 using vinculin as a loading control.
(F) Levels of CLIC3 protein in A2780-DNA3 and A2780-Rab25 cells plated onto plastic or CDM were determined by western blotting.
Developmental Cell
CLIC3, a5b1 Recycling, and Cancer
132 Developmental Cell 22, 131–145, January 17, 2012 ª2012 Elsevier Inc.
Developmental Cell
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microenvironments and in human tumors. Moreover, CLIC3
levels dictate metastasis and poor patient survival, thus high-
lighting the importance of integrin trafficking to cancer progres-
sion in vivo.
RESULTS
CLIC3 Is Upregulated in a Rab25 and 3D Matrix-
Dependent Fashion
We plated A2780 cells stably expressing either Rab25 (A2780-
Rab25) or a control vector (A2780-DNA3) onto plastic or cell-
derived matrix (CDM)—a thick, pliable matrix composed mainly
of fibrillar collagen and fibronectin that recapitulates aspects
of the matrix found in connective tissues—and compared
their mRNA profiles using Affymetrix arrays. We ranked gene
expression changes primarily according to the less conservative
step-up p value (one that controls for false discovery rate) and
secondarily according to fold changes (see Table S1 available
online), and this revealed CLIC3 to be the most significant
Rab25-upregulated gene when cells were plated onto CDM,
but not following adherence to plastic surfaces (Figure 1A).
To confirm CLIC3 induction, mRNA from A2780-DNA3 and
A2780-Rab25 cells was analyzed by real-time quantitative PCR
(qPCR). CLIC3 mRNA was induced 6-fold by Rab25 on plastic
dishes, and this increased to >20-fold when cells were adherent
to CDM (Figure 1B). Moreover, CLIC3 mRNA expression in
A2780-Rab25 cells was reduced by siRNA of Rab25 (but not
Rab11) (Figures 1B and 1C), indicating that altered regulation
of CLIC3 levels was not due to clonal variation between the
two A2780 lines but was Rab25 specific.
We generated a highly specific polyclonal antibody that rec-
ognized CLIC3, but not CLIC1 and CLIC4: the two CLIC family
members most closely related to CLIC3 (Figure 1D). Our anti-
CLIC3 recognized a protein of the expected molecular weight
(27 kDa) that was abundant in lysates from A2780-Rab25 cells
but barely detectable in control cells (Figure 1E). Moreover,
CLIC3 protein levels were somewhat increased by plating
A2780-Rab25 cells on CDM (Figure 1F), and this was opposed
by knockdown of Rab25 (Figure 1C). Conversely, siRNA of
CLIC3 did not alter Rab25 levels (Figure 1G).
To evaluate the relationship between Rab25 and CLIC3
expression in tumor cells, we compared their mRNA and protein
levels in a large cohort of pancreatic and ovarian tumors (see
Figure S1 for validation of Rab25 and CLIC3 antibodies).
Rab25 and CLIC3 levels correlated with one another in both
pancreatic and ovarian carcinoma (Figure 1H). These data indi-
cate that elevated Rab25 is associated with enhanced CLIC3
expression both in a cell culture model and human tumors.
Rab25-Dependent Sorting of Ligand-Engaged a5b1
to CLIC3-Positive Late Endosomes/Lysosomes
In glass-attached A2780-Rab25 cells, Cherry-CLIC3 was not
present at early (EEA1) or recycling (Rab11) endosomes(G) Levels of Rab25 protein in A2780-Rab25 cells following CLIC3 suppression (
(H) Spearman’s correlations indicating a positive relationship between CLIC3
carcinoma. Protein expression was assessed by histoscoring, gene expression (m
on the plots. See also Figure S1 for validation of in-house antibodies recognizing
Developm(Figures S2A and S2B) but colocalized with the late endosomal
marker Rab7 (Figure S2C), and was particularly coincident
with LAMP1, Sialin (Figures 2A and 2B), and lysotracker (Fig-
ure S2D), which are well-established markers of late endo-
somes/lysosomes. Many Rab25-positive structures colocalized
with Rab11a and internalized transferrin, particularly in the
perinuclear region, consistent with previous observations that
this GTPase is located at recycling endosomes (Figure 2C)
(Casanova et al., 1999). Nevertheless, many Rab25-positive
structures did not colocalize with Rab11a or internalized trans-
ferrin but displayed marked coincidence with LAMP1 (Fig-
ure 2C) and Rab7 (data not shown), indicating that Rab25
was also present at late endosomes. Moreover, Rab11a did
not colocalize with LAMP1, indicating that late and recycling
endosomes are morphologically distinct in these cells (Fig-
ure 2C). Examination of time-lapse movies indicated a relation-
ship between Rab25 and CLIC3-positive endosomes, such that
the two structures appear frequently to contact one another
and remain in close apposition for z20 s at a time (see arrows
and inset in Figure 2D; Movie S1). We have quantified the
number and duration of contact events occurring between
Rab25 and CLIC3 structures, and compared these with those
observed between the CLIC3 compartment and Rab11 recy-
cling endosomes. Rab25 endosomes contact CLIC3 structures
on average 1.8 ± 0.2 times/min/cell, and these events persist,
on average, for 21 ± 2.4 s (Figure 2D). By contrast, contact
events between Rab11 endosomes and CLIC3 structures are
fewer (0.9 ± 0.2 times/min/cell) and persist for less time (9 ±
2.0 min). Taken together, these data indicate that Rab25 is
localized not only to recycling endosomes but also to a late
endosomal population that is distinct from Rab11/transferrin
endosomes. Furthermore, Rab25-positive structures contact
the CLIC3 compartment (which is also late endosomal/
lysosomal in nature) significantly more than do recycling
endosomes.
Fibronectin, the main ligand for a5b1, is known to be trans-
ported to lysosomes following internalization (Shi and Sottile,
2008). Consistently, we found that fluorescently labeled soluble
fibronectin accumulated in late endosomes/lysosomes to
colocalize closely with CLIC3 (Figures 2A, 2B, and S2C), sug-
gesting that ligand-occupied a5b1 may also be trafficked
toward lysosomes. Indeed, quantitative fluorescence imaging
indicated that addition of soluble fibronectin to A2780-Rab25
cells promoted delivery of a5b1 to CLIC3-positive late endo-
somes/lysosomes (Figure 2E). Conversely, in the absence of
Rab25, fibronectin did not increase colocalization of a5b1
with CLIC3 (Figure 2E), indicating that Rab25 plays a role in di-
recting fibronectin-occupied a5b1 heterodimers to the lyso-
somal system.
The Conformational Status of a5b1 Dictates Its Late
Endosomal/Lysosomal Sorting
Binding of fibronectin to integrins leads to structural reor-
ganization such that they assume an active conformationusing siRNA) were determined by western blotting.
and Rab25 gene and protein expression in patients with PDAC and ovarian
RNA) by microarray hybridization. Spearman’s rho and p values are indicated
Rab25 and CLIC3.
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Figure 2. Rab25 Is Required for Sorting of Active a5b1 to CLIC3-Positive Late Endosomes/Lysosomes
(A–D) A2780-Rab25 cells were transfected with the indicated fluorescently tagged proteins and incubated with Alexa647 fibronectin (2.5 mg/ml) or Alexa488
transferrin (10 mg/ml) as indicated. The distribution of the fluorescent proteins was determined by live confocal microscopy. In (A)–(C) single images were
acquired, in (D) confocal sections were captured at 2 s intervals over a period of 2 min, and six time points from this sequence (0, 4, 8, 12, 16, and 20 s) are shown.
Scale bars, 10mm. The number and duration of contact events between CLIC3-positive structures and Rab25 (black filled circles) or Rab11a (red filled circles)
vesicles were quantified and are presented as a scatterplot and a histogram. The stills in (D) are extracted from Movie S1. See also Figure S2.
(E) A2780-Rab25 or A2780-DNA3 cells were transfected with Cherry-CLIC3 (red) and either GFP-a5 or GFP-CA-a5 and incubated with or without fibronectin
(FN, 2.5 mg/ml). ImageJ was used to quantify colocalization between CLIC3 and a5, as indicated in the lower panel. Colocalization is expressed as a percentage
of yellow pixels versus red pixels. Values are mean ± SEM from at least four experiments (n > 30 cells). Scale bars, 10 mm.
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from within the cell by association of cytoplasmic proteins,
such as talin, or by introduction of point mutations that weaken
intermolecular interactions between the a- and b-integrin cyto-
tails (Hughes et al., 1996). Previous studies have shown that
F1025Amutation in the a5 integrin cytodomain leads to constitu-
tive a5b1 activation (Webb et al., 2007). Using an antibody
specific for the active conformation of b1 (9EG7), we found
that addition of fibronectin or expression of constitutively active
a5 (CAa5) increased the amount of immunoprecipitable active b1
integrin (Figure S3A). This was independent of Rab25 status,
indicating that this GTPase does not influence fibronectin’s
ability to activate b1 integrins.
9EG7 staining colocalized with Sialin in fixed A2780-Rab25
cells (Figure S3B), indicating that active-conformation integrins
can be sorted to late endosomes/lysosomes. Consistently,
quantitative fluorescence imaging indicated that GFP-tagged
CAa5 (GFP-CAa5) integrin was localized to CLIC3-positive late
endosomes/lysosomes (Figure 2E) even in the absence of added
fibronectin. Moreover, transport of GFP-CAa5 to CLIC3 vesicles
was not apparent in A2780 cells that did not express Rab25
(Figure 2E).
These data indicate that active-conformation a5b1 hetero-
dimers are routed to late endosomes/lysosomes where they co-
localize with CLIC3, and that Rab25 (which is also located on
elements of the late endosomal system) is necessary for this
sorting event.
CLIC3 Controls a5b1 Recycling from Late
Endosomes/Lysosomes
When surface-labeled a5b1 was endocytosed in the absence of
added fibronectin, it returned to the plasma membrane with
largely single order kinetics, and this was unaffected by knock-
down of CLIC3 (Figure 3A). However, following inclusion of
fibronectin during the internalization period, or expression of
CAa5—two situations under which transport of a5b1 to late en-
dosomes/lysosomes is promoted—the integrin recycled with
altered kinetics (Figures 3A–3C). There was an initial, rapid
component to a5b1’s return to the plasma membrane that
was reduced by knockdown of CLIC3 using two independent
siRNA duplexes, or by addition of bafilomycin, a drug that
opposes late endosome/lysosome acidification (Figures 3A–
3C). Moreover, the ability of CLIC3 knockdown to oppose
recycling of CAa5b1 was negated by expression of an siRNA-
resistant ‘‘rescue’’ mutant of CLIC3 (FLAG-CLIC3), but not by
a control vector (pcDNA3) (Figure 3C). We then performed
trafficking assays using the 9EG7 antibody so as to detect
recycling only of active b1 heterodimers. This revealed that
active b1 integrins were returned to the plasma membrane
with kinetics that corresponded to the rapid, CLIC3-dependent
component of recycling (Figures 3A–3C). Moreover, recycling of
active integrin was opposed by CLIC3 knockdown (Figures 3A–
3C), and this was particularly apparent following expression of
CAa5 (Figure 3C). Bafilomycin also suppressed recycling of
the 9EG7-positive integrins in a way that was mostly apparent
at earlier time points (Figure 3A). These data indicate that
CLIC3 is required for recycling of lysosomally targeted a5b1
and that the heterodimers can return to the plasma membrane
in their active conformation.DevelopmVisualization of Integrin Recycling from Late
Endosomes/Lysosomes in Glass-Attached Cells
To visualize integrin recycling from CLIC3-positive late endo-
somes/lysosomes in glass-attached A2780 cells, we used pho-
toactivatable GFP-a5 (paGFP-a5). We expressed paGFP-a5
together with Cherry-CLIC3 and incubated the cells with fibro-
nectin to promote transport of the integrin to late endosomes/
lysosomes. Alternatively, to visualize recycling of integrins in
the active conformation while obviating the need to include
fibronectin, we used a photoactivatable GFP version of CAa5
(paGFP-CAa5). We then aimed a 405 nm laser at a ‘‘single point’’
corresponding to a Cherry-CLIC3-positive vesicle, and this led
to photoactivation of late endosomally/lysosomally localized
wild-type (Figure 3D; Movie S2) or constitutively active (Fig-
ure S4A) integrin. Following this, fluorescence was lost from
the photoactivated vesicle, which was accompanied by
increased fluorescence at an adjacent region of the plasma
membrane (Figures 3D and S4A; Movie S2). Quantification of
movies indicated that both CAa5 and the fibronectin-engaged
wild-type integrin recycled at rates that were indistinguishable
(Figure 3E). Consistent with results from biochemical assays,
paGFP-a5 remained within the CLIC3 compartment following
photoactivation and did not recycle following bafilomycin addi-
tion (Figures 3D and 3E; Movie S3).
While addressing the fate of active a5b1 heterodimers
following CLIC3 knockdown, we found it impossible to photoac-
tivate integrin in late endosomes/lysosomes following CLIC3
knockdown, suggesting that it had been degraded. To address
this, we surface labeled GFP-CAa5 in A2780-Rab25 cells and
used a capture ELISA to record its degradation. Active a5b1
was degraded slowly in control knockdown cells, and this was
markedly increased following siRNA of CLIC3 (Figure 3F). More-
over, expression of an siRNA-resistant CLIC3 ‘‘rescue’’
construct protected CAa5 from degradation in CLIC3 knock-
down cells (Figure 3F).
Taken together, these biochemical and photoactivation-
imaging data indicate that ‘‘active’’ conformation a5b1 hetero-
dimers that have been routed to CLIC3-positive late endo-
somes/lysosomes are not degraded, but rapidly recycled to
the plasma membrane, via a mechanism that requires CLIC3
and lysosome acidification. In the absence of CLIC3, lysosomally
routed a5b1 heterodimers cannot return to the plasma
membrane and are degraded.
Activated a5b1 Integrins Are Transported Retrogradely
during Migration on CDM
A2780-Rab25 cells move on CDM by extending long pseudo-
pods in the direction of migration (Caswell et al., 2007). Fluores-
cence imaging indicated that Rab25 colocalized closely
with LAMP1 (Figure S5A) and Rab7 (data not shown) within the
tip and shaft of these pseudopods. Moreover, there were
frequent and persistent contact events between Rab25 (but
not Rab11) and CLIC3-positive structures that were observable
primarily in the pseudopod shaft (see white arrows in Figures
S5B and S5C). Furthermore, CLIC3 colocalized with LAMP1
(data not shown) and Sialin (Figure S5D), and these late endoso-
mal/lysosomal compartments moved bidirectionally within the
pseudopod shaft, suggesting the possibility that they mediate
transport of cargo to or from the cell front.ental Cell 22, 131–145, January 17, 2012 ª2012 Elsevier Inc. 135
Figure 3. CLIC3 Is Required for Recycling of Activated a5b1 Integrin
(A) A2780-Rab25 cells were either left untransfected or were transfected with nontargeting siRNA (siRNA-NT) or with siRNA targeting CLIC3 (siRNA CLIC3#4).
They were then surface labeled with 0.2 mg/ml NHS-S-S-Biotin at 4C, and internalization was then allowed to proceed for 30 min at 37C in the presence
or absence of 3 mg/ml FN, bafilomycin (100 nM), or vehicle control (DMSO). Biotin remaining at the cell surface was removed by exposure to MesNa at 4C, and
the cells were incubated for the indicated times at 37C. The quantity of biotinylated receptors remaining within the cells was determined by capture ELISA using
microtiter wells coated with monoclonal antibodies recognizing a5 or active b1 (9EG7). Values are mean ± SEM (n = 3 independent experiments).
(B) A2780-Rab25 cells were transfected with nontargeting (siRNA-NT) or siRNA oligonucleotide targeting CLIC3 (siRNA-CLIC3#4), in conjunction with GFP-a5.
Recycling assays were performed in the presence of fibronectin (3.0 mg/ml) as for (A). Biotinylated integrins were detected by capture ELISA using antibodies
recognizing GFP or active b1 (9EG7). Values are mean ± SEM (n = 3 independent experiments).
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pseudopod tip and, consistent with previous observations,
paGFP-a5 recycled preferentially at the cell front (Figures 4A
and 4B; Movie S4). By contrast, paGFP-CAa5 did not recycle
primarily at the pseudopod tip but was retrogradely trafficked
to the cell rear (Figures 4C and 4E; Movie S5). Retrograde traf-
ficking of paGFP-CAa5 was opposed by bafilomycin (Figures
4D and 4E; Movie S6), which blocks recycling of active a5b1
in glass-attached cells (Figure 3). Indeed, in the presence of
bafilomycin, paGFP-CAa5 did not efficiently recycle at the cell
rear but appeared to move slowly from the photoactivated
vesicle to more rearward late endosomes (Figure 4D) that
were LAMP1 and CLIC3 positive (Figure S4B). Further experi-
ments indicated that paGFP-CAa5 photoactivated within
Cherry-CLIC3 vesicles toward the cell front did not recycle at
the pseudopod tip but was destined for other intracellular
compartments and the plasma membrane in the cell rear
(Figure S4C).
Taken together, these data indicate that when cells migrate on
CDM, wild-type a5b1 is recycled at the cell front, whereas integ-
rins locked in the active conformation are transported backward
via the CLIC3/lysosomal pathway and recycled at the rear.
CLIC3 Is Required forMigration onCDMand for Invasion
into 3D Microenvironments
When CLIC3 knockdown A2780-Rab25 cells were plated onto
CDM, they moved, on average, more slowly than control cells,
and this was rescued by re-expression of an siRNA-resistant
form of CLIC3 (Figure 5A). Moreover, pseudopods at the front
of CLIC3 knockdown (but not control) cells became longer with
increasing plating time on CDM (Figures 5B and 5C). We noticed
that CLIC3 knockdown cells tended to remain stationary for long
periods, but following these pauses they moved quickly forward
as the cell body was released (Figure 5B; Movie S7). To quantify
this, we defined a cell that moved less than 3 mm within 90 min
as one that was engaged in ‘‘pausing.’’ CLIC3 knockdown or
addition of bafilomycin markedly increased the duration and
incidence of these pauses, and this was restored to control
levels by re-expression of CLIC3 (Figures 5C and 5D). Further-
more, the limited pausing that was exhibited by control cells
was reduced to almost negligible levels by addition of soluble
fibronectin or expression of CAa5 integrin (Figure 5C), indicating
that CLIC3’s ability to transport active integrin contributes to
the suppression of cellular pausing.(C) A2780-Rab25 cells were transfected with GFP-CA-a5 in conjunction with
CLIC3#3 and #4), as indicated. CLIC3 suppression with oligonucleotide #4 was re
vector (FLAG-CLIC3). Recycling assays were performed in the presence of fibro
ELISA using antibodies recognizing GFP or active b1. Values are mean ± SEM (n
(D and E) A2780-Rab25 cells were transfected with Cherry-CLIC3 in conjunction w
(paGFP-CAa5). The cells were incubated with fibronectin (FN; 2.5 mg/ml) or fibr
recycling from CLIC3 vesicles was visualized using photoactivation, which was
by the white arrows. Images were captured with a confocal microscope every 2 s
and stills corresponding to frames prior to photoactivation, immediately after pho
10 mm (D). The integrated fluorescence intensity of the photoactivated region (ve
each frame of the movie, and these values were plotted against time. Values are m
for paGFP-CAa5, and n = 8 for paGFP-a5 +FN +BAF) (E). See also Movies S2 an
(F) A2780-Rab25 cells were transfectedwithGFP-CA-a5 in conjunction with nonta
CLIC3 suppression was rescued using CLIC3 rescue vector (+FLAG-CLIC3), as i
capture ELISA and antibodies recognizing GFP.
DevelopmTo determine the effect of CLIC3 knockdown on cell move-
ment during the period inwhich cells weremoving, we calculated
the frame-to-frame displacement of cells while they were not
pausing, and we have termed this the ‘‘momentary velocity.’’
Consistent with our observations that CLIC3 cells tend to
‘‘jump’’ forward following release of the cell body and rear (Fig-
ure 5B; see arrow in Movie S7), we found that momentary
velocity was increased following CLIC3 knockdown or bafilomy-
cin addition (Figures 5C and 5D). These data indicate that CLIC3
is required to coordinate cell body translocation with pseudopod
extension to enable pause-free cell migration.
A2780-Rab25 cells invade fibronectin-supplemented Matrigel
in an a5b1-dependent fashion (Caswell et al., 2007). Suppres-
sion of CLIC3 (with four independent siRNA sequences, or
a ‘‘SMARTPool’’) consistently reduced the penetration of
A2780-Rab25 cells into fibronectin-supplemented Matrigel
over a 48 hr period (Figure 5E). Transient expression of GFP-
Rab25 (which is insufficient to drive CLIC3 expression) had
limited capacity to invade fibronectin-supplemented Matrigel
(Figure 5F) (Caswell et al., 2007). We therefore tested whether
CLIC3 could collaborate with Rab25 to drive invasion when ex-
pressed transiently. Indeed, A2780 cells transiently expressing
both GFP-Rab25 and FLAG-CLIC3 displayed similar invasive-
ness to the stable A2780-Rab25 (endogenously CLIC3-express-
ing) cells (Figure 5F).
To determine whether CLIC3 influences the ability of tumor
cells to thrive in 3D microenvironments over a more prolonged
period, we generated A2780-Rab25 lines that stably express
small hairpin RNA (shRNA) duplexes to suppress CLIC3 levels
(Figure 6A). These CLIC3 knockdown lines had similar capacity
to grow and survive on plastic surfaces as control knockdown
cells (Figure 6A). We then assessed growth and invasiveness
of these cells in organotypic gels formed from acid-extracted
rat tail collagen preconditioned with human dermal fibroblasts
that are thought to closely recapitulate a tumor stromal environ-
ment (Marsh et al., 2008). Control A2780 cells moved into orga-
notypic matrices and survived in considerable numbers over
a 14 day period (Figure 6B). By contrast, CLIC3 knockdown
clone #1 cells invaded and survived in reduced numbers, and
knockdown clone #2 cells (which displayed a much greater
reduction of CLIC3 protein) were undetectable following
a 14 day incubation period (Figure 6B). These data indicate
that CLIC3 is required for movement of Rab25-expressing
A2780 cells into Matrigel, and also for their sustained growthnontargeting (siRNA-NT) or siRNA oligonucleotides targeting CLIC3 (siRNA-
scued using either a control vector (pcDNA3) or siRNA-resistant CLIC3 rescue
nectin (3.0 mg/ml) as for (A). Biotinylated integrins were detected by capture
= 3 independent experiments).
ith photoactivatable a5 integrin (paGFP-a5) or constitutively active a5 integrin
onectin in conjunction with bafilomycin (BAF; 100 nM), as indicated. Integrin
performed with a 405 nm laser aimed at CLIC3-positive vesicles, as denoted
over a period of 120 s. Movies were generated from these time-lapse images,
toactivation (0 s), and subsequently at 15 s intervals are presented. Scale bars,
sicle) and adjacent plasma membrane region (membrane) was calculated for
ean ± SEM from eight individual experiments (n = 14 for paGFP-a5+FN, n = 43
d S3 and Figure S4A.
rgeting (siRNA-NT) or siRNA oligonucleotide targetingCLIC3 (siRNA-CLIC3#4).
ndicated. Degradation of a5 integrin was monitored over a period of 8 hr using
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Figure 4. Conformationally Active Integrins Are Trafficked Retrogradely in Cells Migrating on CDMs
A2780-Rab25 cells were transfected with Cherry-Rab25 in conjunction with photoactivatable a5 integrin (A; paGFP-wt-a5) or a constitutively active version of
the probe (C and D; paGFP-CA-a5). Cells were plated onto CDMs 6 hr prior to imaging and either left untreated (A and C) or treated with bafilomycin (D).
Integrin recycling from Rab25 vesicles toward the tips of extending pseudopods was visualized using photoactivation, which was performed with a 405 nm
laser aimed at Rab25-positive vesicles, as denoted by the white arrows. Images were captured with a confocal microscope over a period of 140 s. Movies
were generated from these time-lapse images, and stills presented correspond to frames prior to photoactivation, immediately after photoactivation,
and subsequently at intervals as indicated. Scale bars, 10 mm. Yellow arrow indicates the direction of migration. The integrated fluorescence intensity of
the photoactivated region and plasma membrane regions at the cell front and cell rear (yellow dotted lines) was calculated for each frame of the movie.
Relative fluorescence intensity (vesicle) or percent increase in fluorescence intensity (region) was plotted against time (B and E). Values are mean ± SEM
from more than three individual experiments (n = 6 for paGFP-wt-a5, n = 19 for paGFP-CA-a5 +DMSO, n = 11 for paGFP-CA-a5 +BAF). See also Movies S4,
S5, and S6.
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matrices.
Activated integrins can alter cell-invasive behavior by recruit-
ing focal adhesion kinase leading to activation and autophos-
phorylation of Src on tyrosine416. Integrin-mediated Src activa-
tion is required for tumor cell invasion (Brunton and Frame,
2008), and the use of phospho-specific antibodies to detect
levels of phosphotyrosine416-Src is a robust way to determine
integrin signaling in tissue sections. Active phospho-Src was
clearly visible at the plasma membrane of A2780-Rab25 cells
both within and near the top of the organotypic plug (Figure 6C).
However, in CLIC3 knockdown cells levels of phospho-Src
were significantly reduced, as indicated by quantitative anal-
ysis of anti-phospho-Src immunohistochemical signal (brown
pixels) with respect to the hematoxylin stain (blue pixels) (Fig-
ure 6C). Importantly, the histoscore values for CLIC3 and
phospho-Src were strongly correlated with one another in
pancreatic adenocarcinoma (Figure 6D), indicating the possi-
bility that CLIC3 is associated with upregulated integrin sig-
naling in vivo.
CLIC3 Expression in Ovarian and Pancreatic Cancer
Because we have found that CLIC3 acts to recycle integrins that
have been targeted to late endosomes/lysosomes by the action
of Rab25, we wished to evaluate the expression of CLIC3 in
cancers thought to be driven by Rab25. High levels of Rab25
have been shown to correlate with poor prognosis and aggres-
siveness of ovarian cancers (Cheng et al., 2004), so we initially
looked at CLIC3 in patient samples from this disease. We de-
tected CLIC3 expression in various types of ovarian tumors
including serous (Figure 7A), endometrioid, clear cell, and
mucinous carcinoma (data not shown) primarily in punctate
cytoplasmic structures but also within the nucleus of some
tumors. Ovarian tumors can be categorized into type I, which
includes low-grade micropapillary serous carcinoma, mucinous,
endometrioid, and clear cell carcinomas, and type II, which
comprises high-grade serous carcinomas, malignant mixed
mesodermal tumors, and undifferentiated carcinomas and is
commonly highly invasive and much more likely to present with
disseminated disease (Vang et al., 2009). Histoscore analysis
indicated that CLIC3 protein levels were higher in type II than
in type I ovarian tumors (Figure 7B), supporting a potential role
for this protein in cancer invasion. Moreover, Rab25 levels
were similarly elevated in type II tumors, further supporting the
close relationship between this GTPase and CLIC3 (Figure 7B).
Given the histological and pathophysiological similarities
between ovarian and pancreatic cancers (Hruban et al., 2007),
we analyzed CLIC3 expression in neoplastic lesions of the
human pancreas. CLIC3 was undetectable in ductal and acinar
tissues of normal human pancreas (Figure 7C). Pancreatic
cancers are thought to arise via precursor lesions called pan-
creatic intraepithelial neoplasms (PanINs) (Hruban et al., 2000).
Examination of early PanINs revealed that CLIC3 expression
was low within well-organized epithelia (Figure 7C, green
arrows), whereas dysplastic PanIN regions were more abundant
in CLIC3 (Figure 7C; red arrows). CLIC3 was highly expressed
in pancreatic ductal adenocarcinoma (PDAC) (Figure 7C), being
localized to cytoplasmic granules but also observable in the
nucleus of some cancers with high CLIC3 levels. Moreover,DevelopmCLIC3 expression was highly enriched in regions where the
tumors were invading normal tissue (Figure 7C), suggesting
a role for CLIC3 in the invasive/metastatic behavior of pancreatic
cancer.
CLIC3 Predicts Metastasis and Poor Survival in PDAC
To determine the relationship between CLIC3 levels and metas-
tasis in vivo, we performed immunohistochemistry on a tissue
microarray (TMA) containing 118 cases (6 cores per patient) of
PDAC. Levels of CLIC3 did not differ in terms of tumor size,
grade, stage, vascular invasion, or resection margin status. In
univariate analysis, high CLIC3 expression at both the protein
(Figure 7E) and mRNA (Figure 7F) levels was associated with
significantly decreased survival following resection of PDAC.
Moreover, tumors removed from patients presenting with a
lymph node ratio >50% had elevated levels of CLIC3 by com-
parison with those with lower levels of lymph node involvement
(Figure 7D). Most importantly, in multivariate Cox proportional-
hazards regression analysis, high CLIC3 expression remained
an independent predictor of poor survival (Table S2).
Rab25 has been reported to both promote and oppose tumor
progression. We considered whether these conflicts in the
literature may, in part, be explained by Rab25’s capacity to
elevate CLIC3 levels in the tumor in question. Indeed, although
the correlation between Rab25 and CLIC3 in pancreatic tumors
is highly statistically significant, this relationship is not hard and
fast, and there are many tumors that express Rab25 that do
not express CLIC3 and vice versa (Figure 1H). In low CLIC3
expressors, high Rab25 levels were associated with signifi-
cantly increased patient survival (Figure 7G). Conversely,
Rab25 levels do not predict good clinical outcomes when
CLIC3 is expressed (Figure 7G). Taken together, these data
indicate that in the absence of CLIC3, Rab25 acts as a tumor
suppressor. However, by driving CLIC3 expression, Rab25
increases tumor aggressiveness.
DISCUSSION
Here we demonstrate a pathway for trafficking of activated a5b1
integrins in tumor cells that relies first on the ability of Rab25
to sort active heterodimers toward lysosomes, and then on
CLIC3 to mediate the return of a5b1 from late endosomes/
lysosomes to the cell surface. Routing of receptors to lysosomes
normally leads to their degradation. Indeed, a recent publication
has shown that activated a5b1 integrins are ubiquitinylated,
trafficked to lysosomes, and degraded (Lobert et al., 2010). We
concur that this is indeed the fate of lysosomally targeted integ-
rins in the absence of CLIC3 expression. However, Rab25 is
associated with elevated CLIC3 in both cultured A2780 cells
and in pancreatic and ovarian tumors, and CLIC3 functions to
return lysosomally targeted a5b1 to the plasma membrane,
thus opposing receptor degradation. Moreover, although it
appears that fibronectin and a5b1 part company during passage
through the late endosome/lysosome (data not shown), photo-
activation experiments and biochemical recycling assays
indicate that the integrin need not, and does not, return to the
inactive conformation prior to recycling. Thus, rather than
switching conformations as they move through the endosomal
pathway, integrins may be segregated into spatially distinctental Cell 22, 131–145, January 17, 2012 ª2012 Elsevier Inc. 139
Figure 5. Knockdown of CLIC3 Causes Migrating Cells to Pause and Suppresses Invasion into Fibronectin-Supplemented Matrigel
(A–D) A2780-Rab25 cells were transfected with nontargeting siRNA (si-NT) or with an siRNA targeting CLIC3 (oligo#4) (si-CLIC3), in combination with a5 integrin
(a5b1), constitutively active a5 integrin (CAa5b1), and an siRNA-resistant CLIC3 rescue vector (rescue) as indicated. Transfected cells were plated onto CDM in
the presence or absence of soluble fibronectin (2.5 mg/ml), with or without bafilomycin (10 nM), and allowed to adhere for 24 hr prior to time-lapse microscopy.
Images were captured every 5min over an 8 hr period, and movies were generated from these. Excerpts from thesemovies are displayed in (B) (Movie S7). Scale
bar in (B) is 100 mm. The position of the cell nucleus was followed using cell-tracking software, and the averagemigration speed (A) and the distance between the
center of the nucleus and the cell front (with respect to the direction of migration) (B; pseudopod length) were measured. We used in-house software to identify
periods during which cells moved less than 3 mm in 90 min and defined this as a ‘‘pause’’ in cell migration. The number and duration of pausing events are plotted
in (C). The speed that cells move when they are not pausing is termed the ‘‘momentary velocity,’’ and these values are also plotted in (C). Values are mean ± SEM
(n > 90 track plots); ****p < 0.001, **p < 0.005, Mann-Whitney U test. Representative migration tracks are displayed and aligned (with cell movement running from
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Figure 6. CLIC3 Is Required to Maintain Src Signaling and for Growth and Survival of Cells in Organotypic Matrices
(A–C) The effect of CLIC3 suppression on growth and survival of A2780-Rab25 cells in rat tail collagen preconditioned with human primary fibroblasts was
assessed using stable knockdown cell lines (A). A2780-Rab25 cells were stably transfected with nontargeting shRNAi (NTsh) or a shRNA vector targeting CLIC3
(CLIC3 sh#1 or sh#2). Protein levels were determined by western blotting, and growth rates on plastic surfaces were assessed by cell counting. Cells were
allowed to invade into the collagenmatrix for 14 days, and invasion was assessed by counting the number of cells remaining in the plug (B). Phospho-Src staining
of NTsh and CLIC3sh clones grown in the collagen matrix and quantification of phospho-Src positivity (C). Representative images and intermediate composite
projections that were used for quantification with ImageJ software are shown. Nuclear staining served as internal control, and phospho-Src positivity was
expressed as a ratio of brown pixels (phospho-Src) versus blue pixels (hematoxylin nuclear staining).
(D) Spearman’s correlation indicating relationship between CLIC3 levels and membranous phosphotyrosine416-Src in pancreatic adenocarcinoma.
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CLIC3, a5b1 Recycling, and Cancercycling pools according to their activation state, with inactive in-
tegrins moving toward the cell front and active ones being trans-
ported retrogradely by the late endosomal system.
It is reasonable to propose that a5b1 that is recycled at the
front contributes to pseudopod elongation, presumably by
engaging fresh ECM. However, effective cell migration needs
coordination of pseudopod extension with release/retraction
of the cell rear. Following CLIC3 knockdown, although ad-
vancing pseudopods continue to extend, the cell body does
not efficiently translocate, causing migrating cells to pause
for extended periods. These data are consistent with a role for
retrograde integrin transport in retraction of the cell rear and/or
release of the cell body from the substratum. In addition to
promoting cell attachment, activated integrins are responsiblethe bottom to the top); the momentary velocity is denoted by a color code, the sc
less than 3 mm in 90 min (pauses) are indicated by white dots in (D). Scale bar, 2
(E and F) A2780-Rab25 cells were transfected with nontargeting (NT), CLIC3 ‘‘SMA
A2780-Rab25 cells were transfected with an empty vector and A2780-DNA3 c
invasiveness of transfected cells into fibronectin-supplemented (25 mg/ml) Matr
as the proportion of cells that migrate further than 30 and 45 mm. Data are mean
****p < 0.001, **p < 0.005, Mann-Whitney U test. CLIC3 protein levels were asse
transfection).
Developmfor signaling events, such as Src activation, which lead to disas-
sembly of adhesions, and CLIC3 is required to maintain active
Src in invading cells. Thus, it is possible that CLIC3-dependent
retrograde integrin transport leads to activation of kinases
such as Src at the cell rear to allow adhesion disassembly. It
may seem counterintuitive to propose that delivery of an acti-
vated adhesion receptor would act to reduce, rather than
increase, adhesion. However, addition of plasma fibronectin
markedly decreases the pausing of cells migrating on CDM,
and this may be owing to the ability of this soluble ligand to
increase the quantity of active a5b1 that is engaged in endocytic
trafficking and signaling to the adhesion disassembly machinery
while decreasing that available for attachment to the substratum.
By comparison with other integrins, a5b1 is particularly effectiveale of which is indicated on the left side of (D). The points at which cells moved
00 mm. See also Movie S7.
RTpool,’’ and four individual siRNA oligonucleotides targeting CLIC3 (#1–4) (E).
ells with GFP-Rab25 or GFP-Rab25 and Flag-CLIC3 in combination (F). The
igel was determined using an inverted invasion assay. Invasion is expressed
± SEM from at least three individual experiments, each performed in triplicate;
ssed by western blotting at the endpoint of the invasion assay (72 hr following
ental Cell 22, 131–145, January 17, 2012 ª2012 Elsevier Inc. 141
Figure 7. CLIC3 Expression Predicts Poor Patient Survival
(A and B) CLIC3 immunohistochemistry of low-grade (type I) and high-grade (type II) serous ovarian cancers. The graphs illustrate the difference in CLIC3
and Rab25 histoscores between type I and type II ovarian tumors (Mann-Whitney U test, p < 0.001 and p = 0.005, respectively).
(C) CLIC3 levels in normal pancreatic tissue, PanIN, and PDAC. Green arrows indicate preserved normal structure of ductal epithelium; red arrows point to
dysplastic areas. H&E and CLIC3 staining of an invasive margin of a high-grade PDAC.
(D) Box plot indicating that tumors from patients with more than 50% lymph node involvement have increased levels of CLIC3.
(E) Box plot illustrating stratification of patients with PDAC into low and high CLIC3 expressors based on histoscore. Kaplan-Meier analysis indicates that patients
with high CLIC3 expression (n = 37) have a poorer outcome than those with low expression (n = 81) following tumor resection (p < 0.01).
(F) Box plot illustrating stratification of patients with PDAC into low and high CLIC3 expressors based on normalized mean gene expression. Kaplan-Meier
analysis showing that patients with high CLIC3mRNA expression (n = 31) have a poorer survival than those with low expression (n = 17) following tumor resection
(p = 0.001).
(G) Box plot illustrating stratification of patients with PDAC into low and high Rab25 expressors based on histoscore. Kaplan-Meier analysis of lowCLIC3 and high
Rab25 expressors (blue), low CLIC3 and low Rab25 expressors (green), and high CLIC3 and high Rab25 expressors (red).
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et al., 2008), and this property may thus contribute to a5b1’s
capacity to promote invasion.142 Developmental Cell 22, 131–145, January 17, 2012 ª2012 ElseviCLIC3’s role in Rab25-driven invasiveness and growth/
survival in organotypic matrices in vitro suggests that recycling
of lysosomally routed a5b1 contributes to metastasis in vivo.er Inc.
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enriched at tumor invasive margins, and that its expression
correlates with lymph node metastases and subsequent death
from disseminated disease. Signaling downstream of activated
integrins cannot only promote cell migration but also other
processes that are associated with metastasis, such as cell
growth and survival. For instance, Src promotes cell transforma-
tion by activating the transcription factor, STAT3, which, in turn,
leads to enhanced expression of genes such as cyclin D1 (Sini-
baldi et al., 2000). It is likely, therefore, that increased cycling
through the CLIC3 pathway may contribute not only to cell
migration but also to growth and survival of metastases by
enhancing the capacity of active a5b1 to activate Src and its
downstream effectors. Furthermore, it is now apparent that
a5b1-dependent Src activation contributes to suppression of
apoptosis in suspended cells (Haenssen et al., 2010), further
supporting a role for a population of mobile ‘‘trafficking’’ hetero-
dimers in activating signaling in a way that does not require
engagement with a substratum.
There are conflicts in the literature as to whether Rab25 func-
tions primarily as a promoter or suppressor of cancer. Loss of
Rab25 is associated with tumor initiation in the colon (Nam
et al., 2010) and ER-negative breast cancer (Cheng et al.,
2006, 2010). Conversely, Rab25 expression correlates with
decreased survival and increased aggressiveness of ovarian
cancer (Cheng et al., 2004), and enhanced invasive migration
of ovarian cancer cells in vitro (Caswell et al., 2007). The present
study may resolve some of these conflicts. We propose that
in tumors where CLIC3 is absent, Rab25 will act to route active
integrins to lysosomes whereupon they will be degraded, thus
terminating integrin signaling. Under these circumstances
Rab25 will likely act as a tumor suppressor. Conversely, in
tumors where Rab25 drives upregulation of CLIC3, lysosomally
routed active integrins will be returned to the plasma mem-
brane, thus avoiding degradation and enabling their continued
signaling to drive tumor progression. Further work will be
necessary to define other key molecular components of the
CLIC3-regulated recycling pathway, and to determine how
these can dictate Rab25’s capacity to promote or retard cancer
progression.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
Stable clones of A2780-DNA3 and A2780-Rab25 cells were generated as
described previously. A2780 cells were cultivated in RPMI supplemented
with 10% (v/v) serum at 37C and 10% CO2. Transfection of all vectors, small
hairpin RNA interference (shRNAi), and siRNA oligonucleotides (Dharmacon)
was carried out using the Amaxa Nucleofector system (solution T, program
A-23) according to manufacturer’s instructions. CDMs were generated as
described previously (Bass et al., 2007; Cukierman et al., 2001), but in
many experiments telomerase-immortalized fibroblasts were substituted for
primary cultured human dermal fibroblasts without any noticeable alteration
to the results.
qPCR Analysis
Cells were plated onto plastic and CDMs for 16 hr, and RNA was extracted
using RNeasy kit (QIAGEN). cDNA was synthesized using ImpromII kit
(Promega). qPCR was performed using SYBR green (QIAGEN), QuantiTect
Primer Assay kits (QIAGEN), and a Chromo4 Engine (Bio-Rad). DDC(t) method
was used to calculate changes in gene expression with b-actin and GAPDH
serving as reference genes.DevelopmAntibody Generation, Immunohistochemistry, and Histoscore
Analysis
Recombinant GST-CLIC3 and His-tagged Rab25 were expressed in
BL21(DE3)pLysS E. coli (GST-tag was removed with PreScission Protease),
and the Rab25 and CLIC3 proteins were affinity purified and used for rabbit
immunization (Eurogentec). Formalin-fixed and paraffin-embedded tissue
sections were dewaxed in xylene and passed through ethanol (23 100%,
13 70%) for rehydration. Heat-induced epitope retrieval was carried out in
TRIS-EDTA (pH 8) buffer. Endogenous peroxidase was then blocked using
3%H2O2/methanol for 5 min before polyclonal rabbit CLIC3-specific antibody
was applied at 1:500 dilution for 45 min at room temperature. Tissue sections
were then incubated in secondary antibody (Dako Envision rabbit kit, K4003)
for 40 min, and the staining was visualized with DAB and counterstained
with Gills Hematoxylin.
TMA
The human pancreaticobiliary and ovarian TMAs were produced in the West
of Scotland Pancreatic Unit, Glasgow Royal Infirmary, and the Experimental
Cancer Medicine Centre, Western General Hospital Edinburgh, respectively.
The respective local Research Ethics Committees approved tissue sample
collection. A total of 1,500 cores from 224 patients with pancreaticobiliary
cancer (including 118 cases with PDAC) were arrayed on the TMA. From
each patient at least six tumor cores (0.6 mm diameter) and two cores of adja-
cent normal tissue were sampled. For the ovarian TMA, 455 single cores were
taken from representative tumor areas identified by a specialist gynecological
pathologist and arrayed on two blocks. Full clinicopathological parameters
and complete follow-up data were available for both tissue sets. To compare
the length of survival between the two pancreatic expressor groups, a log
rank analysis was performed. To adjust for competing risk factors, a Cox
proportional hazards model and univariate analysis were used, and hazard
ratios (HRs) with 95% confidence interval (CI) were reported as an estimate
of the risk for disease-specific death. Clinicopathological parameters that
were identified as significant (p < 0.10) in univariate analysis were incorporated
into the multivariate Cox regression analysis in a backward stepwise fashion.
Statistical significance for independent outcome predictors was set at p %
0.05. Statistical analyses were performed with the SPSS version 15.0 package
(SPSS, Chicago, IL, USA).
For the quantification of CLIC3 and Rab25 RNA levels in pancreatic tumors,
fresh tumor tissue was collected from a more recent cohort of 48 patients with
PDAC following pancreaticoduodenectomy along with 10 normal pancreatic
specimens. Cancerous and normal tissue was frozen and stored at the Glas-
gow Royal Infirmary Biobank storage facility and subsequently underwent
RNA extraction and microarray analysis (Whole Human oligo-Microarray Kit
4 3 44K multiplex format; Agilent Technologies, Santa Clara, CA, USA). A
comparison between normal tissue and PDAC specimens revealed that
CLIC3 was overexpressed in the PDAC specimens. An unsupervised
Kaplan-Meier survival analysis identified CLIC3 as being associated with
outcome. Using the median CLIC3 mRNA expression value of the PDAC
specimens as a cutoff, the cohort stratified into two groups with significantly
different survival outcomes.
Cell Imaging and Photoactivation
A2780 cells were seeded onto glass-bottomed 3 cm plates and imaged with
a 643 objective of an inverted confocal microscope (Fluoview FV1000;
Olympus) in an atmosphere of 5% CO2 at 37
C. Photoactivation of paGFP-
a5 integrin was achieved using a 405 nm laser of thatmicroscope andOlympus
SIM scanner. Colocalization quantification was performed using ImageJ
software, where the confocal images underwent two rounds of local contrast
enhancement (image blurring, subtraction of the blurred image, and subse-
quent contrast enhancement) and threshold adjustment. The number of yellow
pixels was then expressed as a percentage of pixels in the red channel.
Recycling Assays
Integrin recycling assays were performed as described previously in Roberts
et al. (2001). Briefly, A2780-Rab25 cells were serum starved for 1 hr, trans-
ferred to ice, washed twice in cold PBS, and surface labeled at 4C with
0.13 mg/ml NHS-SS-biotin (Pierce) in PBS for 30 min. Following surface
labeling, cells were transferred to RPMI containing 10% FCS with or withoutental Cell 22, 131–145, January 17, 2012 ª2012 Elsevier Inc. 143
Developmental Cell
CLIC3, a5b1 Recycling, and Cancer2.5 mg/ml bovine fibronectin at 37C to allow internalization of tracer. Cells
were returned to ice and washed twice with ice-cold PBS, and biotin was
removed from proteins remaining at the cell surface by reduction with MesNa.
The internalized fraction was then chased from the cells by returning them
to 37CRPMI containing 10%FCSwith or without 2.5 mg/ml bovine fibronectin
at 37C. At the indicated times, cells were returned to ice, and biotin was
removed from recycled proteins by a second reduction with MesNa.
Biotinylated integrins were then determined by capture ELISA as follows.
MaxiSorp 96-well plates (Life Technologies) were coated overnight with
5 mg/ml of the appropriate anti-integrin antibodies (PharMingen #555651 for
a5 integrin or PharMingen 9EG7 for active b1) in 0.05 M Na2CO3 (pH 9.6) at
4C and blocked in PBS containing 0.1% Tween 20 (PBS-T) with 5% BSA
for 1 hr at room temperature. Integrins were captured by overnight incubation
of 50 ml of cell lysate at 4C. Unbound material was removed by extensive
washing with PBS-T, and wells were incubated with streptavidin-conjugated
horseradish peroxidase (Amersham) in PBS-T containing 1% BSA for 1 hr
at 4C. Following further washing, biotinylated integrins were detected by
chromogenic reaction with ortho-phenylenediamine.
Inverse Invasion Assay
Inverse invasion assays were performed as described previously (Hennigan
et al., 1994). Briefly, complete Matrigel was diluted in an equal volume of
ice-cold PBS supplemented with soluble fibronectin (25 mg/ml final concentra-
tion). A total of 100 ml of the diluted Matrigel mix was pipetted into a Transwell
(8 mmdiameter pores), inserted into a well of a 24-well tissue culture plate, and
left to set at 37C. The Transwells were then inverted, and 4 3 104 cells were
placed on the underside of the filter. The Transwells were then coveredwith the
base of the 24-well tissue culture plate so that they made contact with cell
suspension droplets. Cell attachment was allowed to proceed for 4 hr, before
the plate was inverted back and the nonadherent cells were washed off by
three sequential washes in 1 ml of serum-free medium. The Transwells were
placed in 1 ml of serum-free medium, which constituted the lower chamber
of the assay, and 100 ml of 10% FCS-RPMI supplemented with 25 ng/ml
EGF was pipetted on top of the Transwell. The cells were then allowed to
invade into the Matrigel and toward the gradient of serum and EGF for 48 hr
at 37C in the atmosphere of 5% CO2. To visualize cells that migrated into
the Matrigel plug, 4 mM Calcein AM (acetoxymethyl ester of calcein) was
used. After 1 hr at 37C, the cells were imaged by confocal microscopy using
a Leica SP2 confocal microscope and a 203 objective at an excitation wave-
length of 488 nm and emission wavelength of 515 nm. Optical sections were
captured at 15 mm intervals, starting from the underside of the Transwell filter
and moving upward in the direction of cell invasion. The resulting images were
quantified and assembled into invasive strips using ImageJ software. The
threshold fluorescence intensity of the images was set to only register cells
that lay within each individual optical slice, and the sum of the fluorescence
in the sections from 30 or 45 mm and above was divided by the total fluo-
rescence of all the sections, thus giving an invasion index ‘‘beyond 30 or
45 mm,’’ respectively. Data were generated from at least three individual exper-
iments, in which each condition was represented by three Transwells, and
optical sections were taken from at least three areas of each Transwell.
Organotypic Invasion Assays
Approximately 7.5 3 104/ml primary human fibroblasts were embedded in
a matrix of rat tail collagen I. Rat tail tendon collagen was prepared by extrac-
tion with 0.5M acetic acid, to a concentration of2mg/ml. Polymerizedmatrix
was allowed to contract for approximately 7 days and until the fibroblasts
contracted the matrix to a plug of approximately 1.5 cm in diameter. Subse-
quently, 4 3 104 A2780-Rab25 cells were plated onto the matrix and allowed
to grow to confluence for 4 days. The matrix was then transferred onto a metal
grid and raised to the air/liquid interface. The matrix was thus fed from under-
neath with complete media supplemented with 25 ng/ml EGF, which was
changed every 2 days. After 14 days, the plugs were fixed in 4% PFA, paraffin
embedded, sectioned, and stained for H&E or for P-Src and counterstained
with hematoxylin.
Expression Constructs
a5 integrin constructs were expressed as GFP-fusion proteins and were
tagged with GFP at the C terminus (cytoplasmic domain). The GFP a5 integrin144 Developmental Cell 22, 131–145, January 17, 2012 ª2012 Elseviwas generously donated by Donna Webb and is exactly as described in
Laukaitis et al. (2001) and Webb et al. (2007). The human gene sequence for
CLIC3 (a generous gift from Mark Berryman) was inserted into the pEGFP-
C1 vector using XhoI (50 ) and BamHI (30). The EGFP sequence was then
replaced with the red fluorescent protein, mCherry, sequence using AgeI (50)
and XhoI (30) such that the fluorescent tag is attached in frame to the N
terminus of CLIC3. The human sequence of CLIC3 was tagged with the
FLAG epitope at the N terminus using PCR and then inserted into the pcDNA3
expression vector using BamHI (50) and Nod (30). For expression of GST-
tagged proteins, the human sequence of CLIC3 was ligated into the pGEX-
6P-1 vector using BamHI (30 to the prescission site and 50 of the CLIC3
sequence) and Nod (30 to CLIC3).SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, and seven movies
and can be found with this article online at doi:10.1016/j.devcel.2011.11.008.
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